Course Content
🫁 Theme I — Pain and Fatigue
🫁 Theme II — Trauma and Repair
Infection & Inflammation (Foundation II) Module — 3rd Year MBBS
AIM CONCEPT INTEGRATION

Fluoroquinolones, Sulfonamides and Trimethoprim

3rd Year MBBS • Infection and Inflammation • Pharmacology

Connect the major drug targets, antibacterial effects, clinical uses and important cautions for rapid revision.

1. THE TOPIC IN ONE CONNECTED FLOW

These antibacterial drugs act at two different essential bacterial processes. Fluoroquinolones disrupt bacterial DNA handling, while sulfonamides and trimethoprim interrupt folate metabolism. Their clinical usefulness depends on matching the drug’s target, spectrum, pharmacokinetics and adverse-effect profile to the infection being treated.

Drug Selection

Spectrum + infection site + pharmacokinetics
Bacterial Target

DNA enzymes or folate pathway enzymes
Functional Block

DNA replication or folate-dependent synthesis fails
Antibacterial Effect

Reduced bacterial survival or multiplication
Clinical Benefit

Treatment of susceptible infections
Limits to Use

Resistance + toxicity + interactions
Fluoroquinolone branch:

Fluoroquinolone

DNA gyrase / topoisomerase IV inhibition

abnormal DNA supercoiling and chromosome separation

failure of bacterial DNA replication

bactericidal, concentration-dependent effect.
Co-trimoxazole branch:

Sulfamethoxazole blocks dihydropteroate synthase

trimethoprim blocks dihydrofolate reductase

sequential folate blockade

reduced tetrahydrofolate

impaired nucleic-acid precursor synthesis.

2. KEY CLINICAL CONNECTIONS

Respiratory vs Urinary Drug Selection

Levofloxacin / moxifloxacin improved pneumococcal activity respiratory usefulness.

Moxifloxacin substantial non-renal elimination lower urinary exposure not preferred when high urinary concentrations are required.

Fluoroquinolone PK–PD Connection

Good oral absorption + tissue penetration useful systemic exposure after oral administration.

Higher exposure relative to bacterial susceptibility greater killing concentration-dependent antibacterial effect.

Characteristic Safety Connections

Fluoroquinolones tendon, peripheral nerve and cardiac repolarization toxicity important clinical caution.

Sulfonamides oxidative stress in G6PD deficiency or bilirubin displacement in neonates hemolysis or kernicterus risk.

Important Drug Interactions

Calcium / magnesium / aluminum / iron chelation of oral fluoroquinolone reduced absorption and antibacterial exposure.

Sulfonamide + phenytoin reduced clearance / increased active exposure increased risk of phenytoin toxicity.

3. AIM HIGH-YIELD INTEGRATION REVIEW

Fluoroquinolone target → effect: DNA gyrase/topoisomerase IV inhibition disrupted DNA replication bactericidal activity.
Spectrum → drug choice: ciprofloxacin has strong gram-negative activity including Pseudomonas, while levofloxacin and moxifloxacin provide stronger respiratory pneumococcal coverage.
Moxifloxacin PK → application: half-life about 12 hours prolonged exposure; substantial non-renal elimination limited suitability when high urinary levels are needed.
Fluoroquinolone resistance: target mutation, reduced permeability or increased efflux less effective drug-target interaction reduced susceptibility.
Sulfonamide mechanism: PABA analogue dihydropteroate synthase inhibition reduced bacterial folate synthesis.
Trimethoprim mechanism: dihydrofolate reductase inhibition reduced tetrahydrofolate impaired nucleic-acid precursor synthesis.
Co-trimoxazole logic: sulfamethoxazole + trimethoprim blockade of two successive folate steps stronger antibacterial effect against susceptible organisms.
Adverse-effect mechanism → clinical clue: sulfonamides may cause crystalluria, G6PD-related hemolysis and neonatal bilirubin displacement, while trimethoprim may produce folate-related marrow effects and hyperkalemia.
AIM Exam Trap:
Sulfonamides inhibit dihydropteroate synthase, whereas trimethoprim inhibits dihydrofolate reductase. Fluoroquinolones act on DNA gyrase/topoisomerase IV rather than the folate pathway.

Scroll to Top
💬 WhatsApp Support